For more information, visit Forward-Looking Statements
SILO STOCK LICENSE
Silo’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the healthcare industry. is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as Alzheimer’s, PTSD, and other rare neurological disorders. Immediately after the reverse stock split becomes effective, the Company will have approximately 1,987,906 shares of common stock issued and outstanding.Īdditional information concerning the reverse stock split can be found in Silo Pharma’s definitive proxy statement filed with the Securities and Exchange Commission on February 14, 2022.
The reverse stock split is intended to enable the Company to meet the stock price requirement for initial listing on The Nasdaq Capital Market.Īs a result of the reverse stock split, every 50 shares of issued and outstanding common stock will be exchanged for 1 share of common stock, with any fractional shares being rounded up to the next higher whole share. The Company has filed an application to list its common stock on The Nasdaq Capital Market and believes it satisfies the financial and liquidity requirements for listing other than the minimum share price requirement. The fifth character “D” will remain appended to the Company’s symbol for 20 business days or until the Company is listed on Nasdaq, whichever comes first, at which point the Company’s trading symbol will revert back to “SILO.” The reverse stock split will become effective at the open of business on Thursday, September 15, 2022, and the Company’s common stock will begin trading on the OTC Markets system on a split-adjusted basis under the temporary ticker symbol “SILOD” at that time. 15, 2022 (GLOBE NEWSWIRE) - Silo Pharma, Inc. (OTCQB: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, announced today that it will effect a 1-for-50 reverse split of its common stock in preparation for the planned listing of the Company’s securities on The Nasdaq Capital Market (“Nasdaq”).
If you are good with personal finance and are looking to invest, you will find the Silo Pharma on NASDAQ stock exchange.ENGLEWOOD CLIFFS, NJ, Sept. Trading in bull markets is always easier so you might want to favor these shares under the given circumstances, but always read up on optimal investment strategies if you are new to investing. Since this share has a positive outlook we recommend it as a part in your portfolio. Our Ai stock analyst implies that there will be a positive trend in the future and the SILO shares might be good for investing for making money. Currently there seems to be a trend where stocks in the Healthcare sector(s) have been popular in this period. According to present data Silo Pharma's SILO shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Recommendations: Buy or sell Silo Pharma stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Silo Pharma share forecasts, stock quote and buy / sell signals below.
0 kommentar(er)
